J. Ulmer

I. Orme, J. Ulmer, D. Montgomery, 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Vaccination with Plasmid DNA Encoding Mycobacterial Antigen 85A Stimulates a CD4+ and CD8+T-Cell Epitopic Repertoire Broader than That Stimulated byMycobacterium tuberculosis H37Rv Infection

J. Ulmer, T. P. van den Berg, K. Huygen, 1998, Infection and Immunity.

Alum's adjuvant action: grease is the word

M. Mbow, J. Ulmer, E. D. Gregorio, 2011, Nature Medicine.

Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice.

J. Ulmer, R. Xiang, Manmohan J. Singh, 2003, Vaccine.

DNA vaccines against tuberculosis.

I. Orme, J. Ulmer, R. Deck, 1998, Novartis Foundation symposium.

Human clinical trials of plasmid DNA vaccines.

J. Ulmer, Margaret A. Liu, 2005, Advances in genetics.

Mechanisms of action of DNA vaccines.

C. Walker, J. Ulmer, M. Selby, 1998, Expert opinion on investigational drugs.

Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells

J. Ulmer, J. Donnelly, R. Deck, 1996, Immunology.

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

J. Ulmer, D. Montgomery, K. Huygen, 1997, Vaccine.

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.

H. Liao, B. Haynes, D. Montefiori, 2015, The Journal of infectious diseases.

Microparticles and DNA Vaccines

J. Ulmer, J. Donnelly, Manmohan J. Singh, 2006 .

H 37 Rv Infection tuberculosis Mycobacterium than That Stimulated by T-Cell Epitopic Repertoire Broader + and CD 8 + Mycobacterial Antigen 85 A Stimulates a CD 4 Vaccination with Plasmid DNA Encoding

Van Den, J. Ulmer, K. Huygen, 1998 .

DNA vaccines for bacteria and viruses.

J. Ulmer, J. Donnelly, R. Deck, 1996, Advances in experimental medicine and biology.

Influenza Virus Challenge Correlation with Protective Immunity Against Frequency Induced by a DNA Vaccine and Dose Dependence of CTL Precursor

J. Ulmer, J. Donnelly, T. Fu, 1999 .

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.

J. Ulmer, J. Donnelly, T. Fu, 1998, Vaccine.

Characterization of Immune Responses Induced by Intramuscular Vaccination with DNA Vaccines Encoding Measles Virus Hemagglutinin and/or Fusion Proteins

M. Levine, J. Ulmer, M. Song, 2005, Journal of Virology.

Attenuated Salmonella enterica Serovar Typhi and Shigella flexneri 2a Strains Mucosally Deliver DNA Vaccines Encoding Measles Virus Hemagglutinin, Inducing Specific Immune Responses and Protection in Cotton Rats

M. Levine, G. Losonsky, J. Ulmer, 2003, Journal of Virology.

Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis

Alan D. Roberts, I. Orme, J. Ulmer, 1998, Infection and Immunity.

In vivo phosphorylation of myelin basic proteins: single and double isotope incorporation in developmentally related myelin fractions.

J. Ulmer, P. Braun, P. E. Braun, 1986, Developmental biology.

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

P. Mason, S. Bertholet, E. De Gregorio, 2015, Journal of Virology.

DNA vaccines for HIV/AIDS

J. Ulmer, B. Wahrén, Margaret A. Liu, 2006, Current opinion in HIV and AIDS.

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

J. Shiver, K. Leander, J. Ulmer, 1993, DNA and cell biology.

Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus Immunization

Gary J. Nabel, Ling Xu, Rino Rappuoli, 2005, Journal of Virology.

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

S. Bertholet, E. De Gregorio, J. Ulmer, 2016, PloS one.

Technical and regulatory hurdles for DNA vaccines.

J. Ulmer, J. Donnelly, K. Berry, 2003, International journal for parasitology.

DNA Vaccination

R. Rappuoli, J. Ulmer, 2003, Current protocols in human genetics.

Vaccination with Polynucleotides: A Novel Means of Generating Immunity

J. Ulmer, J. Donnelly, Margaret A. Liu, 1994 .

Immunogenicity by Electroporation In Vivo Increased DNA Vaccine Delivery and

J. Ulmer, M. Selby, D. Rabussay, 2000 .

Targeting and processing of glycophorins in murine erythroleukemia cells: use of brefeldin A as a perturbant of intracellular traffic.

G. Palade, J. Ulmer, Jeffrey B. Ulmer, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Microparticles for the delivery of DNA vaccines

J. Ulmer, Manmohan J. Singh, D. O’hagan, 2004, Immunological reviews.

Cationic Microparticles and Emulsions As Effective Delivery Systems for Immune Stimulatory CpG DNA

J. Ulmer, Manmohan J. Singh, D. O’hagan, 2004 .

Quantification of the number of cytotoxic T cells specific for an immunodominant HCV-specific CTL epitope primed by DNA immunization.

J. Ulmer, G. Otten, X. Paliard, 2000, Vaccine.

Nonviral delivery of self-amplifying RNA vaccines

Thomas Krucker, Rino Rappuoli, Yen Cu, 2012, Proceedings of the National Academy of Sciences.

Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.

P. Mason, J. Ulmer, C. Schmaljohn, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection

E. Fikrig, J. Bernhagen, R. Bucala, 2018, Nature Communications.

Recent innovations in mRNA vaccines.

J. Ulmer, A. Geall, 2016, Current opinion in immunology.

Enhancement of DNA vaccine potency using conventional aluminum adjuvants.

R. K. Evans, W. Mcclements, D. Volkin, 1999, Vaccine.

Immunization with DNA.

J. Ulmer, J. Donnelly, M. A. Liu, 1994, JIM - Journal of Immunological Methods.

Stopping pandemics before they start: Lessons learned from SARS-CoV-2

R. Baric, E. Saphire, J. Ulmer, 2022, Science.

Delivery Systems for Gene-based Vaccines

J. Ulmer, Margaret A. Liu, T. Dubensky, 2000, Molecular medicine.

Innate immunity and biodefence vaccines

J. Ulmer, N. Valiante, D. O’hagan, 2003, Cellular microbiology.

A major endothelial plasmalemmal sialoglycoprotein, gp60, is immunologically related to glycophorin.

G. Palade, J. Ulmer, J. Schnitzer, 1990, Proceedings of the National Academy of Sciences of the United States of America.

CpG Oligodeoxynucleotides Adsorbed onto Polylactide-Co-Glycolide Microparticles Improve the Immunogenicity and Protective Activity of the Licensed Anthrax Vaccine

B. Ivins, J. Ulmer, Manmohan J. Singh, 2005, Infection and Immunity.

RNA-based vaccines.

C. Mandl, P. Mason, J. Ulmer, 2012, Vaccine.

Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.

J. Shiver, K. Leander, J. Ulmer, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Neonatal Immunization with a Sindbis Virus-DNA Measles Vaccine Induces Adult-Like Neutralizing Antibodies and Cell-Mediated Immunity in the Presence of Maternal Antibodies1

M. Levine, J. Ulmer, J. Polo, 2006, The Journal of Immunology.

Maternal Antibodies Cell-Mediated Immunity in the Presence of Adult-Like Neutralizing Antibodies and Virus-DNA Measles Vaccine Induces Neonatal Immunization with a Sindbis

M. Levine, J. Ulmer, J. Polo, 2006 .

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.

H. Mollenkopf, S. Kaufmann, B. Knapp, 2004, Vaccine.

Influenza DNA vaccines.

J. Ulmer, 2002, Vaccine.

DNA Vaccines: Immunogenicity and Preclinical Efficacy

J. Ulmer, J. Donnelly, M. A. Liu, 1999 .

Relative Potency of Cellular and Humoral Immune Responses Induced by DNA Vaccination

J. Ulmer, M. Selby, G. Otten, 2001, Intervirology.

Antigen presentation and DNA vaccines.

J. Ulmer, J. Donnelly, Margaret A. Liu, 2000, American journal of respiratory and critical care medicine.

Priming of hepatitis C virus–specific cytotoxic t lymphocytes in mice following portal vein injection of a liver‐specific plasmid DNA

M. Houghton, J. Ulmer, W. Manning, 2000, Hepatology.

Injection in Mice Their Immunogenicity After Intramuscular Distribution of DNA Vaccines Determines

D. McDonald, J. Ulmer, J. Donnelly, 2000 .

DNA vaccines for viral diseases.

J. Ulmer, J. Donnelly, 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

5 Art and Science of DNA Vaccines

J. Ulmer, J. Donnelly, Margaret A. Liu, 1998 .

DNA vaccines. Mechanisms for generation of immune responses.

J. Ulmer, J. Donnelly, T. Fu, 1998, Advances in experimental medicine and biology.

Toward the development of DNA vaccines.

J. Ulmer, J. Donnelly, M. A. Liu, 1996, Current opinion in biotechnology.

Overview Biologicals & Immunologicals Recombinant vaccines: technology and applications

J. Ulmer, J. Donnelly, Margaret A. Liu, 1995 .

Pore formation and mitogenicity in blood cells by the class 2 protein of Neisseria meningitidis.

J. Ulmer, J. Donnelly, A. Friedman, 1992, The Journal of biological chemistry.

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine.

J. Ulmer, J. Donnelly, R. Deck, 1997, Vaccine.

ELI's coming: expression library immunization and vaccine antigen discovery.

J. Ulmer, M. A. Liu, M. Liu, 1996, Trends in microbiology.

Protein expression in vivo by injection of polynucleotides.

J. Shiver, J. Ulmer, J. Donnelly, 1994, Current opinion in biotechnology.

Toward the development of better vaccine adjuvants

J. Ulmer, 2002, Expert opinion on biological therapy.

Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo

J. Ulmer, M. Selby, D. Rabussay, 2000, The Journal of Immunology.

DNA Vaccines Against RNA Viruses

J. Ulmer, 2003 .

Tuberculosis DNA Vaccines

J. Ulmer, 2001 .

Tuberculosis DNA Vaccines

J. Ulmer, 2001, Scandinavian journal of infectious diseases.

Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA.

J. Ulmer, R. Deck, D. Montgomery, 1997, Cellular and molecular biology.

Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.

R. K. Evans, J. Ulmer, J. Smith, 2000, Vaccine.

Interaction of myelin basic protein and proteolipid protein

J. Ulmer, A. Edwards, P. Braun, 1989, Journal of neuroscience research.

Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines

J. Ulmer, Manmohan J. Singh, M. Schaefer, 2001, Journal of Virology.

DNA vaccines.

J. Ulmer, J. Donnelly, D. Montgomery, 2021, Methods in molecular medicine.

8 – Prospects for Induction of Mucosal Immunity by DNA Vaccines

J. Shiver, J. Ulmer, J. Donnelly, 1996 .

Immunization against Viral Proteins with Naked DNA

J. Ulmer, J. Donnelly, R. Deck, 1995, Annals of the New York Academy of Sciences.

Protective Efficacy of Intramuscular Immunization with Naked DNA

J. Ulmer, J. Donnelly, Margaret A. Liu, 1995, Annals of the New York Academy of Sciences.

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines.

J. Ulmer, J. Donnelly, R. Deck, 1994, Vaccine.

Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity.

J. Ulmer, J. Donnelly, T. Fu, 1997, Vaccine.

Induction of immunity by DNA vaccination: application to influenza and tuberculosis.

I. Orme, J. Ulmer, J. Donnelly, 1997, Behring Institute Mitteilungen.

Chloroform markedly stimulates the phosphorylation of myelin basic proteins.

J. Ulmer, P. E. Braun, 1987, Biochemical and biophysical research communications.

In vivo phosphorylation of myelin basic proteins: age-related differences in 32P incorporation.

J. Ulmer, P. Braun, P. E. Braun, 1986, Developmental biology.

DNA Vaccines

J. Ulmer, J. Donnelly, M. A. Liu, 2006, Methods in Molecular Medicine™.

DNA vaccines.

J. Shiver, J. Ulmer, J. Donnelly, 1997, Annual review of immunology.

Effects of Brefeldin A on the Golgi complex, endoplasmic reticulum and viral envelope glycoproteins in murine erythroleukemia cells.

G. Palade, J. Ulmer, 1991, European journal of cell biology.

Vaccine manufacturing: challenges and solutions

Rino Rappuoli, Jeffrey B Ulmer, R. Rappuoli, 2006, Nature Biotechnology.

Vaccine Adjuvants: Mode of Action

E. De Gregorio, J. Ulmer, E. Caproni, 2013, Front. Immunol..

Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

R. Deering, J. Ulmer, Luis A. Brito, 2014, Expert opinion on drug delivery.

RNA: the new revolution in nucleic acid vaccines.

C. Mandl, J. Ulmer, A. Geall, 2013, Seminars in immunology.

Heterologous protection against influenza by injection of DNA encoding a viral protein.

J. Ulmer, J. Donnelly, P. Felgner, 1993, Science.

Targeting the innate immune response with improved vaccine adjuvants

Jeffrey B Ulmer, J. Ulmer, N. Valiante, 2005, Nature Medicine.

The phosphorylation of myelin proteins

J. Ulmer, 1988, Progress in Neurobiology.

Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination.

J. Ulmer, R. Deck, D. Montgomery, 1997, Vaccine.

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

Donna L. Montgomery, Olivier Denis, I. Orme, 1996, Nature Medicine.

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

C. Mandl, P. Dormitzer, P. Mason, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene-based vaccines.

J. Ulmer, M. A. Liu, M. Liu, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines

J. Ulmer, J. Donnelly, Hong Liu, 2003, Journal of Virology.

Role of Neutralizing Antibodies in Protective Immunity Against HIV

J. Ulmer, I. Srivastava, S. Barnett, 2005, Human vaccines.

Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design

J. Ulmer, I. Srivastava, S. Barnett, 2004, Expert review of vaccines.

Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action.

R. Rappuoli, J. Ulmer, Giulietta Maruggi, 2021, Current topics in microbiology and immunology.

Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus

L. Stamatatos, J. Ulmer, J. Donnelly, 2002, Journal of Virology.

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

J. Ulmer, J. Donnelly, T. Fu, 1997, Journal of virology.

Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice.

J. Ulmer, J. Donnelly, A. Friedman, 1998, Vaccine.

Presentation of an exogenous antigen by major histocompatibility complex class I molecules

J. Ulmer, J. Donnelly, Margaret A. Liu, 1994, European journal of immunology.

Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation.

J. Ulmer, J. Donnelly, D. Rabussay, 2006, Vaccine.

Self-amplifying mRNA vaccines.

C. Mandl, P. Dormitzer, P. Mason, 2015, Advances in genetics.

High Frequencies of PD-1+TIM3+TIGIT+CTLA4+ Functionally Exhausted SARS-CoV-2-Specific CD4+ and CD8+ T Cells Associated with Severe Disease in Critically ill COVID-19 Patients

S. Prakash, Ruchi Srivastava, H. Vahed, 2022, bioRxiv.

Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses

A. Folgori, R. Cortese, A. Nicosia, 2014, Journal of Virology.

Characterization of Immune Responses Induced by Intramuscular Vaccination with DNA Vaccines Encoding Measles Virus Hemagglutinin and/or Fusion Proteins

M. Levine, J. Ulmer, M. Song, 2005, Journal of Virology.

Attenuated Salmonella and Shigella as Carriers for DNA Vaccines

J. Ulmer, F. Xu, 2003, Journal of drug targeting.

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

J. Ulmer, Giulietta Maruggi, Dong Yu, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain

D. Montefiori, P. Luciw, J. Ulmer, 2005, Journal of Virology.

A therapeutic SIV DNA vaccine elicits T-cell immune responses, but no sustained control of viremia in SIVmac239-infected rhesus macaques.

Brigitte E. Sanders-Beer, J. Ulmer, J. Donnelly, 2008, AIDS research and human retroviruses.

Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines.

Yide Sun, L. Stamatatos, J. Ulmer, 2006, Virology.

Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants

J. Ulmer, N. Valiante, A. Pashine, 2006, Immunopotentiators in Modern Vaccines.

Antibody-guided structure-based vaccines.

P. Kwong, B. Dekosky, J. Ulmer, 2020, Seminars in immunology.

Elegantly presented DNA vaccines

J. Ulmer, 1997, Nature Biotechnology.

HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies

R. Rappuoli, K. Montin, F. Dallocchio, 2012, PloS one.

Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein in MF59 Adjuvant

J. Ulmer, J. Donnelly, I. Srivastava, 2010, Journal of Virology.

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

J. Ulmer, J. Donnelly, Manmohan J. Singh, 2003, Journal of Virology.

Vaccines on demand, part II: future reality

Z. Kis, J. Ulmer, A. Geall, 2022, Expert opinion on drug discovery.

Quantitative assessment of antigen-specific CD8+ T cells in the mouse: application to vaccine research.

J. Ulmer, G. Otten, S. Barnett, 2003, Immunology letters.

An update on the state of the art of DNA vaccines.

J. Ulmer, 2001, Current opinion in drug discovery & development.

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models

Tiffany F. Chen, Taru S. Dutt, M. Ringenberg, 2022, Molecular Therapy.

Microparticle-based technologies for vaccines.

J. Ulmer, Manmohan J. Singh, D. O’hagan, 2006, Methods.

Vaccines ‘on demand’: science fiction or a future reality

J. Ulmer, A. Geall, M. Mansoura, 2015, Expert opinion on drug discovery.

Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

D. G. Gibson, J. Gill, Z. Qi, 2013, Emerging Microbes & Infections.

Response from Ulmer, Donnelly and Liu

J. Ulmer, J. Donnelly, Margaret A. Liu, 1993 .

Humoral and cellular immunities elicited by DNA vaccines: Application to the human immunodeficiency virus and influenza

J. Shiver, J. Ulmer, J. Donnelly, 1996 .

Application of Mycobacterial Proteomics to Vaccine Design: Improved Protection by Mycobacterium bovis BCG Prime-Rv3407 DNA Boost Vaccination against Tuberculosis

H. Mollenkopf, S. Kaufmann, B. Knapp, 2004, Infection and Immunity.

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella.

J. Ulmer, Mei Hong, Fengfeng Xu, 2003, Vaccine.

Cyclic AMP decreases the phosphorylation state of myelin basic proteins in rat brain cell cultures.

F. Mcmorris, J. Ulmer, A. Edwards, 1987, The Journal of biological chemistry.

DNA vaccines.

J. Ulmer, J. Donnelly, D. Montgomery, 1997, Pharmacology & therapeutics.

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ

N. Sardesai, J. Ulmer, G. Otten, 2013, Vaccines.

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination.

J. Ulmer, J. Donnelly, A. Friedman, 1997, Vaccine.

Development of a potent Zika virus vaccine using self-amplifying messenger RNA

Jessica L. Cohen, J. Mascola, T. Pierson, 2020, Science Advances.

Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates.

L. Stamatatos, R. Diaz-Avalos, R. Cheng, 2008, Virology.

Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.

J. Ulmer, J. Donnelly, C. Greer, 2006, Vaccine.

Safety Challenges Facing Next Generation Vaccines and the Role for Biomarkers

E. Oviedo-Orta, J. Ulmer, S. S. Ahmed, 2013 .

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant

Jerome H. Kim, H. Liao, B. Haynes, 2018, PloS one.

The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

J. Mascola, L. Stamatatos, A. Gettie, 2001, Journal of Virology.

New developments and concepts related to biomarker application to vaccines

S. Black, J. Ulmer, S. S. Ahmed, 2012, Microbial biotechnology.

Glycophorin expression in murine erythroleukaemia cells.

G. Palade, J. Ulmer, E. Dolci, 1989, Journal of Cell Science.

Common peptide epitopes in glycophorin and the endothelial sialoglycoprotein gp60.

G. Palade, J. Ulmer, J. Schnitzer, 1992, Biochemical and biophysical research communications.

Structural Characteristics Predict the Stability of HIV

J. Ulmer, I. Srivastava, M. Franti, 2011 .

Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C.

R. Rappuoli, J. Ulmer, J. Donnelly, 2005, Microbes and infection.

DNA vaccines: recent technological and clinical advances.

J. Ulmer, B. Wahrén, Margaret A. Liu, 2006, Discovery medicine.

Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins

D. Montefiori, T. Dubensky, D. Driver, 2005, Journal of Virology.

Stabilization of HIV-1 Envelope in the CD4-bound Conformation through Specific Cross-linking of a CD4 Mimetic*

D. Montefiori, R. Guérois, Hocine Madaoui, 2011, The Journal of Biological Chemistry.

Enhancement of DNA vaccine potency by electroporation in vivo.

J. Ulmer, M. Selby, C. Goldbeck, 2000, Journal of biotechnology.

Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen.

M. Levine, J. Ulmer, J. Szabo, 2008, Human gene therapy.

Sindbis Virus-Based Measles DNA Vaccines Protect Cotton Rats against Respiratory Measles: Relevance of Antibodies, Mucosal and Systemic Antibody-Secreting Cells, Memory B Cells, and Th1-Type Cytokines as Correlates of Immunity

M. Levine, J. Ulmer, M. Pasetti, 2009, Journal of Virology.

Science and society – vaccines: Ethical issues for vaccines and immunization

J. Ulmer, Margaret A. Liu, 2002, Nature Reviews Immunology.

Stabilization of HIV-1 envelope in the CD4-bound conformation through specific cross-linking of a CD4 mimetic.

D. Montefiori, R. Guérois, Hocine Madaoui, 2011, The Journal of Biological Chemistry.

A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide.

J. Ulmer, I. Srivastava, S. Barnett, 2008, Virology.

Effects of brefeldin A on the processing of viral envelope glycoproteins in murine erythroleukemia cells.

G. Palade, J. Ulmer, 1991, The Journal of biological chemistry.

Small Molecule Immunopotentiators as Vaccine Adjuvants

J. Ulmer, N. Valiante, Fengfeng Xu, 2006 .

Enhancement of vaccine potency through improved delivery

J. Ulmer, 2004, Expert opinion on biological therapy.

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge

L. Stamatatos, J. Ulmer, J. Donnelly, 2006, Retrovirology.

Delivery of DNA vaccines by attenuated intracellular bacteria.

W. Goebel, S. Kaufmann, J. Ulmer, 1999, Immunology today.

Nonviral delivery of self-amplifying RNA vaccines

C. Mandl, R. Rappuoli, P. Dormitzer, 2012, Proceedings of the National Academy of Sciences.

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

C. Mandl, P. Dormitzer, P. Mason, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

RNA-based vaccines.

C. Mandl, P. Mason, J. Ulmer, 2012, Vaccine.

Vaccines research and development: poised for rapid growth

R. Rappuoli, J. Ulmer, 2007 .